These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8787813

  • 1. Inactivation of (1-->3)-beta-D-glucan in mice.
    Miura T, Ohno N, Suda M, Miura NN, Shimada S, Yadomae T.
    Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro.
    Okazaki M, Adachi Y, Ohno N, Yadomae T.
    Biol Pharm Bull; 1995 Oct; 18(10):1320-7. PubMed ID: 8593430
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice.
    Ohno N, Asada N, Adachi Y, Yadomae T.
    Biol Pharm Bull; 1995 Jan; 18(1):126-33. PubMed ID: 7735226
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
    Ohno N, Kurachi K, Yadomae T.
    J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
    [Abstract] [Full Text] [Related]

  • 5. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice.
    Suda M, Ohno N, Hashimoto T, Koizumi K, Adachi Y, Yadomae T.
    FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):93-100. PubMed ID: 8880133
    [Abstract] [Full Text] [Related]

  • 6. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
    Suda M, Ohno N, Adachi Y, Yadomae T.
    J Pharmacobiodyn; 1992 Aug; 15(8):417-26. PubMed ID: 1479542
    [Abstract] [Full Text] [Related]

  • 7. Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice.
    Miura NN, Ohno N, Aketagawa J, Tamura H, Tanaka S, Yadomae T.
    FEMS Immunol Med Microbiol; 1996 Jan; 13(1):51-57. PubMed ID: 8821398
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inactivation of a particle beta-glucan by proteins in plasma and serum.
    Miura T, Ohno N, Miura NN, Shimada S, Yadomae T.
    Biol Pharm Bull; 1997 Oct; 20(10):1103-7. PubMed ID: 9353573
    [Abstract] [Full Text] [Related]

  • 11. Modulation of antitumor activity of grifolan by subsequent administration of (1----3)-beta-D-glucanase in vivo.
    Nono I, Ohno N, Ohsawa M, Oikawa S, Yadomae T.
    J Pharmacobiodyn; 1989 Oct; 12(10):581-8. PubMed ID: 2517127
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the antitumor effect and tissue distribution of highly branched (1-->3)-beta-D-glucan, SSG, by carrageenan.
    Suda M, Ohno N, Adachi Y, Yadomae T.
    Biol Pharm Bull; 1995 May; 18(5):772-5. PubMed ID: 7492998
    [Abstract] [Full Text] [Related]

  • 13. Resistance of highly branched (1-->3)-beta-D-glucans to formolysis.
    Ohno N, Terui T, Chiba N, Kurachi K, Adachi Y, Yadomae T.
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1057-60. PubMed ID: 7641306
    [Abstract] [Full Text] [Related]

  • 14. Th1/Th2-Balancing immunomodulating activity of gel-forming (1-->3)-beta-glucans from fungi.
    Suzuki Y, Adachi Y, Ohno N, Yadomae T.
    Biol Pharm Bull; 2001 Jul; 24(7):811-9. PubMed ID: 11456123
    [Abstract] [Full Text] [Related]

  • 15. Increase of hematopoietic responses by triple or single helical conformer of an antitumor (1-->3)-beta-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic mice.
    Tsuzuki A, Tateishi T, Ohno N, Adachi Y, Yadomae T.
    Biosci Biotechnol Biochem; 1999 Jan; 63(1):104-10. PubMed ID: 10052129
    [Abstract] [Full Text] [Related]

  • 16. Immunopharmacological and immunotoxicological activities of a water-soluble (1-->3)-beta-D-glucan, CSBG from Candida spp.
    Tokunaka K, Ohno N, Adachi Y, Tanaka S, Tamura H, Yadomae T.
    Int J Immunopharmacol; 2000 May; 22(5):383-94. PubMed ID: 10708886
    [Abstract] [Full Text] [Related]

  • 17. Failure in antitumor activity by overdose of an immunomodulating beta-glucan preparation, sonifilan.
    Miura T, Miura NN, Ohno N, Adachi Y, Shimada S, Yadomae T.
    Biol Pharm Bull; 2000 Feb; 23(2):249-53. PubMed ID: 10706395
    [Abstract] [Full Text] [Related]

  • 18. Physiochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan "grifolan LE" from Grifola frondosa.
    Adachi Y, Ohno N, Ohsawa M, Sato K, Oikawa S, Yadomae T.
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1838-43. PubMed ID: 2805163
    [Abstract] [Full Text] [Related]

  • 19. Distribution of grifolan NMF-5N (I/B), a chemically modified antitumor beta-glucan in mice.
    Takeyama T, Suzuki I, Ohno N, Oikawa S, Sato K, Ohsawa M, Yadomae T.
    J Pharmacobiodyn; 1988 Jun; 11(6):381-5. PubMed ID: 3171879
    [Abstract] [Full Text] [Related]

  • 20. Relationship between the tissue distribution and antitumor activity of highly branched (1-->3)-beta-D-glucan, SSG.
    Suda M, Ohno N, Adachi Y, Yadomae T.
    Biol Pharm Bull; 1994 Jan; 17(1):131-5. PubMed ID: 8148801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.